Evidence map›Paper›PMID 39185101›Full record

ArticleNeurology. Clinical practice2024

Virtual Compared With In-Person Neurologic Examination Study.

Lauren Hophing, Tiffany Tse, Nicole Naimer, Mario Masellis, Saira S Mirza, Aaron Izenberg, Houman Khosravani, Charles D Kassardjian, Sara B Mitchell

Abstract read
In one paragraph

Article in Neurology. Clinical practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lauren HophingDivision of Neurology (LH, MM, AI, HK, CDK, SBM), Department of Medicine; Neurology Quality and Innovation Lab (LH, TT, NN, HK, CDK, SBM); Division of Neurology (MM, AI, HK, SBM), Department of Medicine, Sunnybrook Health Sciences Centre; Sunnybrook Research Institute (MM, SSM, HK, SBM), University of Toronto, Ontario, Canada; Division of Neurology (CDK), Department of Medicine; Li Ka Shing Knowledge Institute (CDK), St. Michael's Hospital; Department of Psychiatry (SBM), Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; and Azrieli Brian Medicine Fellowship Program (SBM), Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-1159-6423
Tiffany TseDivision of Neurology (LH, MM, AI, HK, CDK, SBM), Department of Medicine; Neurology Quality and Innovation Lab (LH, TT, NN, HK, CDK, SBM); Division of Neurology (MM, AI, HK, SBM), Department of Medicine, Sunnybrook Health Sciences Centre; Sunnybrook Research Institute (MM, SSM, HK, SBM), University of Toronto, Ontario, Canada; Division of Neurology (CDK), Department of Medicine; Li Ka Shing Knowledge Institute (CDK), St. Michael's Hospital; Department of Psychiatry (SBM), Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; and Azrieli Brian Medicine Fellowship Program (SBM), Toronto, Ontario, Canada.ORCID https://orcid.org/0009-0004-5303-0585
Nicole NaimerDivision of Neurology (LH, MM, AI, HK, CDK, SBM), Department of Medicine; Neurology Quality and Innovation Lab (LH, TT, NN, HK, CDK, SBM); Division of Neurology (MM, AI, HK, SBM), Department of Medicine, Sunnybrook Health Sciences Centre; Sunnybrook Research Institute (MM, SSM, HK, SBM), University of Toronto, Ontario, Canada; Division of Neurology (CDK), Department of Medicine; Li Ka Shing Knowledge Institute (CDK), St. Michael's Hospital; Department of Psychiatry (SBM), Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; and Azrieli Brian Medicine Fellowship Program (SBM), Toronto, Ontario, Canada.ORCID https://orcid.org/0009-0001-7278-4874
Mario MasellisDivision of Neurology (LH, MM, AI, HK, CDK, SBM), Department of Medicine; Neurology Quality and Innovation Lab (LH, TT, NN, HK, CDK, SBM); Division of Neurology (MM, AI, HK, SBM), Department of Medicine, Sunnybrook Health Sciences Centre; Sunnybrook Research Institute (MM, SSM, HK, SBM), University of Toronto, Ontario, Canada; Division of Neurology (CDK), Department of Medicine; Li Ka Shing Knowledge Institute (CDK), St. Michael's Hospital; Department of Psychiatry (SBM), Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; and Azrieli Brian Medicine Fellowship Program (SBM), Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-6244-2096
Saira S MirzaDivision of Neurology (LH, MM, AI, HK, CDK, SBM), Department of Medicine; Neurology Quality and Innovation Lab (LH, TT, NN, HK, CDK, SBM); Division of Neurology (MM, AI, HK, SBM), Department of Medicine, Sunnybrook Health Sciences Centre; Sunnybrook Research Institute (MM, SSM, HK, SBM), University of Toronto, Ontario, Canada; Division of Neurology (CDK), Department of Medicine; Li Ka Shing Knowledge Institute (CDK), St. Michael's Hospital; Department of Psychiatry (SBM), Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; and Azrieli Brian Medicine Fellowship Program (SBM), Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-0973-2246
Aaron IzenbergDivision of Neurology (LH, MM, AI, HK, CDK, SBM), Department of Medicine; Neurology Quality and Innovation Lab (LH, TT, NN, HK, CDK, SBM); Division of Neurology (MM, AI, HK, SBM), Department of Medicine, Sunnybrook Health Sciences Centre; Sunnybrook Research Institute (MM, SSM, HK, SBM), University of Toronto, Ontario, Canada; Division of Neurology (CDK), Department of Medicine; Li Ka Shing Knowledge Institute (CDK), St. Michael's Hospital; Department of Psychiatry (SBM), Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; and Azrieli Brian Medicine Fellowship Program (SBM), Toronto, Ontario, Canada.ORCID https://orcid.org/0009-0001-5645-711X
Houman KhosravaniDivision of Neurology (LH, MM, AI, HK, CDK, SBM), Department of Medicine; Neurology Quality and Innovation Lab (LH, TT, NN, HK, CDK, SBM); Division of Neurology (MM, AI, HK, SBM), Department of Medicine, Sunnybrook Health Sciences Centre; Sunnybrook Research Institute (MM, SSM, HK, SBM), University of Toronto, Ontario, Canada; Division of Neurology (CDK), Department of Medicine; Li Ka Shing Knowledge Institute (CDK), St. Michael's Hospital; Department of Psychiatry (SBM), Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; and Azrieli Brian Medicine Fellowship Program (SBM), Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-4059-9420
Charles D KassardjianDivision of Neurology (LH, MM, AI, HK, CDK, SBM), Department of Medicine; Neurology Quality and Innovation Lab (LH, TT, NN, HK, CDK, SBM); Division of Neurology (MM, AI, HK, SBM), Department of Medicine, Sunnybrook Health Sciences Centre; Sunnybrook Research Institute (MM, SSM, HK, SBM), University of Toronto, Ontario, Canada; Division of Neurology (CDK), Department of Medicine; Li Ka Shing Knowledge Institute (CDK), St. Michael's Hospital; Department of Psychiatry (SBM), Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; and Azrieli Brian Medicine Fellowship Program (SBM), Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0001-7117-8787
Sara B MitchellDivision of Neurology (LH, MM, AI, HK, CDK, SBM), Department of Medicine; Neurology Quality and Innovation Lab (LH, TT, NN, HK, CDK, SBM); Division of Neurology (MM, AI, HK, SBM), Department of Medicine, Sunnybrook Health Sciences Centre; Sunnybrook Research Institute (MM, SSM, HK, SBM), University of Toronto, Ontario, Canada; Division of Neurology (CDK), Department of Medicine; Li Ka Shing Knowledge Institute (CDK), St. Michael's Hospital; Department of Psychiatry (SBM), Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; and Azrieli Brian Medicine Fellowship Program (SBM), Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-5621-6922

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: The COVID-19 pandemic forced a shift to virtual care in several neurologic care settings. Little is known about the validity of the virtual neurologic examination (VNE) for clinical decision making when compared with the in-person neurologic examination (IPNE). The objective of this study was to investigate the utility of the VNE in arriving at an accurate localization and diagnosis in comparison with the traditional IPNE in an ambulatory outpatient setting. Methods: A retrospective chart review of patients examined virtually and in-person within 4 months at outpatient general neurology and neuromuscular clinics from 2 tertiary academic care centers during the COVID-19 pandemic was conducted. The Cohen kappa coefficient was calculated to test agreement between virtual and in-person assessment results, and descriptive statistical methods were used to compare accuracy, localization, and diagnosis. Results: A total of 81 patients met the inclusion criteria. Overall, there was fair agreement between VNE and IPNE (64% agreement, Discussion: The high rates of agreement in detecting an abnormality on the VNE and IPNE for some maneuvers and resultant clinical impressions may support the validity of the VNE for initial consultation depending on the clinical scenario. The VNE seems to be a good surrogate evaluation compared with the IPNE for certain chief complaints. The low sensitivity suggests that a normal VNE should warrant further in-person clinical correlation, especially in the context of a highly concerning history. The IPNE is more sensitive in detecting subtle abnormalities on examination, and a low threshold should be used to bring a patient in for an IPNE if the VNE is normal in certain clinical contexts.

Identifiers

PMID39185101
PMCPMC11341002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.